Literature DB >> 8200421

Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle.

H N Doods1, M Entzeroth, H Ziegler, N Mayer, P Holzer.   

Abstract

The present study examined the effects of a series of tricyclic muscarinic receptor antagonists on muscarinic receptors present in the guinea-pig ileum, both in vitro and in vivo. The selectivity profiles of these antagonists and that of atropine were determined by their affinity for cortical muscarinic M1, cardiac M2 and submandibular M3 receptors and for m4 receptors expressed in CHO cells. The compounds pirenzepine, UH-AH 37, AQ-RA 391 and AQ-RA 618 possessed high affinity (pKi 7.94-8.22) for muscarinic M1 receptors. Pirenzepine exhibited the most pronounced muscarinic M1 selectivity. AF-DX 384 and AQ-RA 741 possessed an approximately 10-fold higher affinity for the cardiac muscarinic M2 receptor than AF-DX 116. However, both compounds also exhibited high affinity for muscarinic m4 receptors. High affinity for muscarinic M3 and m4 receptors was observed for UH-AH 37, AQ-RA 391 and AQ-RA 681. The antagonists were then tested for their interaction with the muscarinic receptors which are responsible for the methacholine-induced contraction of longitudinal muscle in vitro, circular muscle in vivo and muscarinic receptors which mediate the distension-evoked ascending reflex contraction of circular muscle in vitro. Compounds showing high affinity for muscarinic M3 receptors (e.g. AQ-RA 618) were the most potent antagonists in the functional experiments. Comparison of the binding displacement data with the functional results indicates that the effects of methacholine on the longitudinal and circular muscle of the guinea-pig ileum were predominantly mediated by muscarinic M3-type receptors. In contrast, the correlation between muscarinic M2 receptor affinity and antagonism of muscarinic receptors in the ileum was very weak.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200421     DOI: 10.1016/0014-2999(94)90202-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Characterization of pre- and postsynaptic muscarinic receptors in circular muscle of pig gastric fundus.

Authors:  Pascal G Leclere; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Muscarinic blockade of methacholine induced airway and parenchymal lung responses in anaesthetised rats.

Authors:  M K Tulić; J L Wale; F Peták; P D Sly
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

3.  Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-09       Impact factor: 3.000

4.  Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.

Authors:  X Zhang; Z-J Feng; K Chergui
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

5.  G-protein involvement in muscarinic receptor-stimulation of inositol phosphates in longitudinal smooth muscle from the small intestine of the guinea-pig.

Authors:  S A Prestwich; T B Bolton
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

6.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

7.  Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.

Authors:  J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

8.  The role of M3 receptors in regulation of electrical activity deteriorates in the rat heart during ageing.

Authors:  Svetlana V Tapilina; Alexandra D Ivanova; Tatiana S Filatova; Pavel A Galenko-Yaroshevsky; Denis V Abramochkin
Journal:  Curr Res Physiol       Date:  2021-12-08

Review 9.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

Review 10.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.